Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultrasound-Guided Fine-Needle Biopsy: A Prospective Comparative Study with Tissue Specimens. | Diagnostics (Basel) | 2023 | 36980386 | PubTator, text mining | PubMed |
| A comprehensive platform for analyzing longitudinal multi-omics data. | Nat Commun | 2023 | 36973282 | PubTator, text mining | PubMed |
| Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell. | Cancer Res | 2023 | 36971477 | PubTator, text mining | PubMed |
| Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53. | Cancer Med | 2023 | 36971051 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis identifies shared immune changes between ischemic stroke and COVID 19. | Front Immunol | 2023 | 36969251 | PubTator, text mining | PubMed |
| Primary central nervous system diffuse large B-cell lymphoma in fourth ventricle: Case report and literature review. | Medicine (Baltimore) | 2023 | 36961159 | PubTator, text mining | PubMed |
| Treatment selection for patients with relapsed or refractory follicular lymphoma. | Front Oncol | 2023 | 36959808 | PubTator, text mining | PubMed |
| CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review. | Radiol Oncol | 2023 | 36942468 | PubTator, text mining | PubMed |
| A theoretical framework of immune cell phenotypic classification and discovery. | Front Immunol | 2023 | 36936975 | PubTator, text mining | PubMed |
| Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis. | Stem Cells Transl Med | 2023 | 36928395 | PubTator, text mining | PubMed |
| Decrypting drug actions and protein modifications by dose- and time-resolved proteomics. | Science | 2023 | 36926954 | PubTator, text mining | PubMed |
| Primary refractory plasmablastic lymphoma: A precision oncology approach. | Front Oncol | 2023 | 36923431 | PubTator, text mining | PubMed |
| Use of exosome transcriptome-based analysis to identify novel biomarkers in patients with locally advanced esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy. | Ann Transl Med | 2023 | 36923096 | PubTator, text mining | PubMed |
| MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas. | Blood Cancer J | 2023 | 36922488 | PubTator, text mining | PubMed |
| Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar. | Acta Haematol | 2023 | 36917966 | PubTator, text mining | PubMed |
| B cell receptor repertoire analysis from autopsy samples of COVID-19 patients. | Front Immunol | 2023 | 36911681 | PubTator, text mining | PubMed |
| The evolving use of measurable residual disease in chronic lymphocytic leukemia clinical trials. | Front Oncol | 2023 | 36910619 | PubTator, text mining | PubMed |
| New insights into the Lck-NF-κB signaling pathway. | Front Cell Dev Biol | 2023 | 36910149 | PubTator, text mining | PubMed |
| Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer. | PNAS Nexus | 2023 | 36909826 | PubTator, text mining | PubMed |
| Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis. | J Oncol | 2023 | 36908705 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=38